Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.

Marsh, Ryan; Dos Santos, Claudio; Hanson, Liam; Ng, Christabella; Major, Giles; Smyth, Alan R; Rivett, Damian; van der Gast, Christopher.

Afiliación

Marsh R; Department of Applied Sciences, Northumbria University , Newcastle, United Kingdom.
Dos Santos C; Department of Natural Sciences, Manchester Metropolitan University , Manchester, United Kingdom.
Hanson L; Department of Natural Sciences, Manchester Metropolitan University , Manchester, United Kingdom.
Ng C; Department of Life Sciences, Manchester Metropolitan University , Manchester, United Kingdom.
Major G; School of Medicine, University of Nottingham , Nottingham, United Kingdom.
Smyth AR; NIHR Nottingham Biomedical Research Centre , Nottingham, United Kingdom.
Rivett D; School of Medicine, University of Nottingham , Nottingham, United Kingdom.
van der Gast C; Nestlé Institute of Health Sciences, Société des Produits Nestlé , Lausanne, Switzerland.

Microbiol Spectr ; : e0117523, 2023 Aug 21.

Article en En | MEDLINE | ID: mdl-37607068